Home » Features » Health » Irritable Bowel Syndrome

Irritable Bowel Syndrome

About Irritable Bowel Syndrome (IBS)

IBS is a common disorders of the gastrointestinal tract. Researchers at Heidelberg University Hospital say that they have uncovered a molecular basis for IBS.

Studies say chronic pain like IBS is more experienced in women than in men.

Scientists have found that a small piece of RNA that blocks a substance protecting the colon membrane, leading to hostile conditions that can produce diarrhea, bloating and chronic abdominal pain.

Irritable Bowel Syndrome in News

Slim Trim 2000 Reviewed by Healthy Nutrition -- Pure Forskolin Formula Revealed
BAYSIDE, NY--(Marketwired - November 21, 2015) - With the discovery of an advanced formula for losing weight fast, trimming the tummy and attaining an in-shape body, Slim Trim 2000 has been introduced with a revolutionary ingredient "Forskolin," which was featured in a famous celebrity show as the finest source of breaking down body fat.

Nucific Bio X4 Reviewed by Healthy Nutrition -- 4 Important Nutrients Revealed
BAYSIDE, NY--(Marketwired - November 17, 2015) - Nucific, a California based health and Development center introduced a 4 special nutrients formula for digestive support, in their newly launched product named "Bio X4." For the purpose of healthy development of the body, Bio X4 is a complete digestive support, also a supplement for weight management as well.

Biomerica Working With FDA on Submission for Its IBS Product
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced today that following a meeting with FDA on September 17, 2015, Biomerica is moving forward with guidance from FDA to develop the optimal clinical and regulatory path to begin clinical studies for its new IBS (Irritable Bowel Syndrome) product

Biomerica Announces Conference Call Regarding Its Product and Recent Developments in the Irritable Bowel Syndrome (IBS) Market
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, will hold a conference call to discuss its product and recent developments in the Irritable Bowel Syndrome (IBS) market on Wednesday, July 8 at 1:30 pm Pacific Time (4:30 Eastern Time). The call will be hosted by Zack Irani-Cohen, Biomerica's Chief Executive Officer.

Biomerica Announces Third Quarter Financial Results and Establishes Scientific Advisory Board
Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $3,467,450 for the nine months ending February 28, 2015, compared to $3,441,299 for the same period in the previous year. Sales for the three months ending February 28, 2015 were $1,299,400 compared to $1,492,719 for the same period last year.

Introducing Nutrexin: Balance, Nourish and Relieve
DILLON, CO--(Marketwired - February 18, 2015) - FATIGUE, ACID REFLUX AND SLEEP DISORDERS -- At some point, many of us have experienced these symptoms and others related to chronic health conditions

Research Now Launches Gastrointestinal Panel
Research Now today announced the launch of its Gastrointestinal Panel, providing a resource for deeper insights into the practices, treatments and sentiments of those who suffer from various forms of gastrointestinal conditions.

Colonoscopy Screening for Colon Cancer: Just One Day Could Save Your Life
Studies have confirmed that screening for colon cancer is a contributing factor to declining colon cancer death rates

Ardelyx Licenses NaP2b Phosphate Inhibitor Program for Kidney Disease to Sanofi in Deal Worth up to $198 Million
Ardelyx, Inc. today announced that it has licensed to Sanofi (NYSE: SNY) (EURONEXT PARIS: SAN) its novel phosphate transport NaP2b inhibitor program (also known as NaPi2b, Npt2b and SLC34A2). Ardelyx will receive an undisclosed upfront payment from Sanofi. Total development and regulatory milestones could potentially reach up to $198 million

Knoxville Bariatric Surgeon and Bari Life Bariatric Supplements Introduces Multi-Probiotics
Dr. Stephen G. Boyce, a board-certified Knoxville bariatric surgeon and developer of Bari Life Bariatric Supplements, says he is excited to add multi-probiotics to his line of bariatric vitamin products. According to a recent Stanford University School of Medicine study, supplementing weight loss surgery patients with probiotics can be beneficial for maximizing weight loss benefits. Dr

Ardelyx Receives $15 Million Milestone as Part of Ongoing Tenapanor Collaboration With AstraZeneca
Ardelyx, Inc. today announced it has received $15 million USD from AstraZeneca (NYSE: AZN) (LSE: AZN), representing a development milestone that was part of the collaboration agreement the companies had previously executed. AstraZeneca and Ardelyx announced the agreement in October 2012 under which AstraZeneca paid $35 million up front, and would pay development milestones of $237

Fertility and Pregnancy: Sydney Naturopath Explains How Natural Solutions Can Help
At Kathleen McFarlane's Sydney naturopathy practice, she uses herbal and nutritional medicine in combination with lifestyle modifications to assist patients with a wide variety of conditions, including IBS (irritable bowel syndrome), stress, anxiety, and excess weight. A significant number of Ms. McFarlane's patients seek out her help with issues regarding reproductive health and fertility

Battelle Continues Data Coordination Center Work for TMD Cooperative Agreement
Battelle has won a $5.2 million follow-on contract to serve as the data coordination center for a series of important studies led by the University of North Carolina at Chapel Hill with funding from the National Institutes of Health

Gabriel Lee, M.D., Joins Houston-Bay Area Gastroenterology
Bay Area Gastroenterology welcomes Board Certified Gastroenterologist Dr. Gabriel Lee to the group -- expanding the scope of services they are able to offer in general and interventional gastroenterology.

Healthy Choices at Every Meal
(Family Features) For families of the nearly 30 percent of the general population who suffer from irritable bowel syndrome, making healthy diet decisions is not an option, it's a necessity -- especially when those sufferers are children and young adults.

Mother's Day Calls to Mind Memories of Loved Ones Lost to Ovarian Cancer
Mother's Day is a time for honoring and celebrating special women -- the ones who gave birth to us, who raised us, who taught us about life and who inspired us

Mauna Kea Technologies Reports Full-Year 2012 Results in Line With Expectations
Mauna Kea Technologies (EURONEXT PARIS: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced its full financial results for the 12 months ended December 31, 2012.

Kalahari Greentech Inc. Announces It Has Signed a Definitive Agreement With Honeymark International, LLC
Kalahari Greentech Inc. (PINKSHEETS: KHGT) (Kalahari, or the Company) is pleased to announce that it has signed a definitive agreement to acquire Honeymark International, LLC (Honeymark), an importer of Manuka Honey and a distributor of natural Manuka Honey products

Mauna Kea Technologies Reports First Cellvizio(R) System Sales in Japan and New Clinical Research on Digestive Cancers and Disorders
Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported its first Cellvizio system sales in Japan, the world's second largest healthcare market.

Mauna Kea Technologies Announces the Publication of World's First Direct Visualization of the Digestive Tract's Nervous System
Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that gastroenterologists in Japan and Germany have used Cellvizio to directly view the enteric nervous system of the digestive tract during an endoscopy procedure for the first time

Mauna Kea Technologies Announces New Data Supporting Clinical Utility of Cellvizio(R)

PropThink: Priority Review For Amitiza Sending SCMP Higher; Big Potential Market
By David MoskowitzSucampo Pharmaceuticals (NASDAQ:SCMP) announced with its partner Takeda Pharmaceuticals that the FDA has granted priority review for its sNDA (supplemental new drug application) for Amitiza in the treatment of OIC (opioid-induced constipation) in patients with chronic, non-cancer pain

PropThink: SGYP Advances 2nd Clinical-Stage GI Treatment; Positive For The Stock
Synergy Pharmaceuticals (NASDAQ:SGYP) recently submitted an IND (Investigational New Drug application) for its IBD (inflammatory bowel disease) treatment, SP-333, and is on track to meet management's objective to begin clinical trials with the compound in the second half of this year

PropThink: Approval of Amitiza For Constipation Improves SCMP Presence in Europe
Sucampo Pharmaceuticals (NASDAQ:SCMP) announced Wednesday that its lead drug, Amitiza, received approval for marketing in the U.K. for chronic idiopathic constipation (CIC). This marks the second approval for Amitiza in Europe, and new indications like Opioid Induced Constipation (OIC) are expected to follow, increasing the market opportunity in the region

PropThink: Several Ways To Play The Linzess (linaclotide) Approval; Buy IRWD, FRX, SCMP, and SGYP
Forest Laboratories (NYSE:FRX) and partner Ironwood Pharmaceuticals (NASDAQ:IRWD) announced FDA approval of Linzess (generically known as linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). The approval came a week early, but was expected

PropThink: Why AMRN and SGYP Could Trade Higher On AstraZeneca's Newly Announced CEO
Amarin Pharmaceuticals (NASDAQ:AMRN) could trade higher as investors digest this morning's news that Roche's (OTC:RHHBY) former Head of Global Pharmaceuticals has joined AstraZeneca (NYSE:AZN) as CEO. Investors expect AMRN to be acquired for its recently approved triglyceride-lowering therapy, Vascepa, and the most logical suitor is AZN

Balboa Press' "Cultured Food Life" Acquired by Hay House Publishing
Balboa Press, a division of Hay House Inc., and leading self-publisher of personal empowerment books, today announced that author Donna Schwenk's holistic health book, "Cultured Food Life," has been acquired for publishing by Hay House, Inc

Synergy Closing Key Trial; Decision On IRWD's Linaclotide Likely To Have Impact
Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that its Phase IIb/III trial testing lead drug plecanatide for chronic constipation is fully enrolled. The trial met its 880 patient target yesterday and the company will officially close enrollment at the end of August

Winthrop-University Hospital Physician Uses Miniature Microscope to Examine Live Tissue at the Cellular Level During Endoscopy
Stavros Stavropoulos, MD, Director of Gastrointestinal Endoscopy and the Advanced Endoscopy Program at Winthrop-University Hospital, is using the world's smallest microscope to view internal tissues at the cellular level in real time during endoscopies

Add Apples to Your Diet for a Happy Belly
Sensitivity to gluten, a protein found in many cereal grains, is fast becoming the most talked-about gastrointestinal issue of our time. However, did you know that 15 percent of Americans suffer from Irritable Bowel Syndrome (IBS), nearly ten times that of Celiac Disease?

Astellas and Drais Partner to Develop Second Astellas Compound Through Seldar
Astellas Pharma Inc. (TSE: 4503) ("Astellas") and Drais Pharmaceuticals, Inc. ("Drais") today announced that they have entered into a second partnership in as many months to develop and commercialize an Astellas compound

Innovative Med Concepts Debuts Revolutionary iPhone(R) App Designed to Monitor Daily Health Habits and Improve Well-Being
Privately held Innovative Med Concepts, LLC today announced the availability of UShapeHealth, a new, user-friendly, mobile health application for the iPhone® intended to help people take better control of their health. UShapeHealth offers a personalized experience with daily suggestions and practical recommendations to help manage and improve one's overall health and general well-being

Couples sharing bed 'happier and healthier'
Partners' snoring habits might have led some couples to sleep in separate rooms.

Bacteria in gut 'play role in irritable bowel syndrome'
A new study has definitively linked an overgrowth of bacteria in the gut to the Irritable Bowel Syndrome (IBS).

Bacterial overgrowth in gut ups Irritable bowel syndrome
A new study has definitively linked an overgrowth of bacteria in the gut to the Irritable Bowel Syndrome (IBS).

IBS patients 'have higher prevalence of traumatic childhood experiences'
Patients with irritable bowel syndrome (IBS) have a significantly greater prevalence of early adverse life events, including general trauma as well as physical, emotional and sexual abuse, a new study has revealed.

Drugs best suited for treating Irritable Bowel Syndrome identified
Two prevalent drug therapies - rifaximin and lubiprostone - have been identified as having the fewest side effects for treating Irritable Bowel Syndrome, according to a study.

Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) today announced that the U.S

Hypnosis provides lasting relief from bowel disorder symptoms
Hypnosis can be a highly effective method of treating irritable bowel syndrome (IBS), say researchers.

Lifetime psychological traumas may lead to irritable bowel syndrome
Researchers have revealed that psychological and emotional traumas experienced over a lifetime - such as the death of a loved one, divorce, natural disaster, house fire or car accident, physical or mental abuse - may lead to adult irritable bowel syndrome (IBS).

Harnessing amazing power of mind can help beat illnesses
Scientists are turning to the amazing power of the mind to fight against many diseases.

Negative emotions significantly affect brain processing of pain
A new study has found that neuroticism, the tendency to experience negative emotions, significantly affects brain processing during pain, as well as during the anticipation of pain.

Chinese herbs could provide new treatment for Parkinson's
A study has indicated that Chinese herb can help treat Parkinson's disease.

Blame your anxiety more on your gut than brain!
For the first time, researchers have concluded that bacteria residing in the gut influence brain chemistry and behaviour.

Digestive problems early in life 'may up depression risk'
A study of laboratory rats by researchers at the Stanford University School of Medicine has indicated that depression and anxiety may result from short-term digestive irritation early in life.

Peppermint relieves irritable bowel disorder
Peppermint may help in relieving irritable bowel syndrome (IBS), which affects up to a fifth of the population.

Ritter Pharmaceuticals, Inc. Announces First Patient Enrollment in Its Phase 2 Clinical Study of RP-G28 for the Treatment of Lactose Intolerance
Ritter Pharmaceuticals, Inc. (Ritter), a pharmaceutical company with a focus on digestive diseases, announced today that clinical investigators have enrolled the first patient in its randomized, double-blind, placebo-controlled Phase 2 study of RP-G28 in patients with symptoms associated with lactose intolerance

Houston-Clear Lake Bay Area Gastroenterology Physician Dr. Sezen Altug to Speak at LiveWell Women's Conference May 26, 2011
Bay Area Gastroenterology consultants of Houston-Clear Lake continue their educational initiative to reduce the number of colon cancer cases diagnosed every year. Dr

Enterologics, Inc. Launches Corporate Website
Enterologics, Inc. (OTCBB: ELGO), a biotechnology company, today announced the launch of The website provides information about the Company, as well as information about probiotics and their potential role for treating individuals with gastrointestinal (GI) disorders.

Comment on this story